| TONIX PHARMACEUTICALS |
| USA |
| Gesundheit |
| US8902608392 / A40VM0 |
| TPM0 (Frankfurt) / TNXP (NASDAQ) |
| FRA:TPM0, ETR:TPM0, TPM0:GR, NASDAQ:TNXP |
| - |
| https://www.tonixpharma.c.. |
|
Tonix Pharmaceuticals Holding Corp., a biopharmace..
>Volltext.. |
| 146.92 Mio. EUR |
| 41.08 Mio. EUR |
| 8.45 Mio. EUR |
| -69.15 Mio. EUR |
| -70.02 Mio. EUR |
| -865.36 EUR |
| 0.42 Mio. EUR |
| 107.78 Mio. EUR |
| -57.53 Mio. EUR |
| 6.58 |
| -28.25% |
| 50.32% |
| - |
| - |
| - |
| - |
| TONIX |
| 27.10.25 |
|